This brand name is authorized in United States. It is also authorized in Lithuania, New Zealand, Poland.
The drug INFANRIX contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
|
2
|
UNII
IRH51QN26H - CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
|
3
|
UNII
QSN5XO8ZSU - BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED)
|
4
|
UNII
8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
|
5
|
UNII
I05O535NV6 - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED)
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J07AJ52 | Pertussis, purified antigen, combinations with toxoids | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AJ Pertussis vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| LT | Valstybinė vaistų kontrolės tarnyba | 1007549 |
| NZ | Medicines and Medical Devices Safety Authority | 7344 |
| PL | Rejestru Produktów Leczniczych | 100224363 |
| US | FDA, National Drug Code | 50090-2883, 58160-810 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.